5PSQ-053 Drug utilisation study of human normal immunoglobulin in haematological and oncologic patients in a teaching paediatric hospital

BACKGROUND: Approved therapeutic indications for human normal immunoglobulin (HNIg) in the paediatric population are: primary immunodeficiency syndromes, hypogammaglobulinaemia post-stem cell transplantation, AIDS with recurrent infections and primary immune thrombocytopenia (ITP), among others. Apa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Main Authors: Busquets, F Bossacoma, Genestar, JL Vinent, Llobet, A Ruiz, Passini, VP Celis, Pasqual, N Arranz, Comes, A, Suárez, J Arrojo, Celma, M Sácnhez
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2018
Assuntos:
Section 5: Patient safety and quality assurance
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535465/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.407
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares